Atlas Trials

Regorafenib in Subjects With Gastrointestinal Stromal Tumors (GIST) Who Have Progressed After Standard Therapy (Managed Access Program)

Clinical trial NCT01689376 · NO_LONGER_AVAILABLE

Trial details

NCT number
NCT01689376
Sponsor
Bayer
Status
NO_LONGER_AVAILABLE
Study type
EXPANDED_ACCESS
Gastrointestinal Stromal Tumors

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.